نتایج جستجو برای: serogroup b

تعداد نتایج: 902654  

Journal: :Journal of preventive medicine and hygiene 2012
A Neri C Fazio A Carannante P Mastrantonio P Stefanelli

In the period 2008-2010, 309 Neisseria meningitidis, isolated in Italy within the National Surveillance of the Invasive Meningococcal Diseases, have been tested for their phenotypic and genotypic characteristics. The main results obtained are: (a) an increase of the strains of serogroup B and a decrease of serogroup C; (b) a phenotypic and genotypic variability of the ST-41/44 clonal complex, t...

Journal: :reports of biochemistry and molecular biology 0
mehrdad gholami department of microbiology, faculty of medicine, iran university of medical sciences, tehran, iran alireza salimi chirani tel: +98 2123872556; fax: +98 2123872556 mona moshiri department of pathobiology, division of microbiology, faculty of public health, tehran university of medical sciences, tehran, iran mansour sedighi department of microbiology, faculty of medicine, iran university of medical sciences, tehran, iran abazar pournajaf department of microbiology, faculty of medicine, iran university of medical sciences, tehran, iran masoud tohidfar agricultural biotechnology research institute of iran, tehran, iran

background: neisseria meningitidis, a life-threatening human pathogen with the potential to cause large epidemics, can be isolated from the nasopharynx of 5–15% of adults. the aim of the current study was to evaluate biophysical and biochemical properties and immunological aspects of chimeric acyl-carrier protein-macrophage infectivity potentiator protein-type iv pilus biogenesis protein antige...

Journal: :FEMS microbiology letters 1998
R Borrow H Claus U Chaudhry M Guiver E B Kaczmarski M Frosch A J Fox

Non-culture diagnosis and serogroup determination of meningococcal infection is important in contact management where vaccination may be possible. A serogroup B and C PCR ELISA assay for the non-culture diagnosis and serogroup determination has proved invaluable for enhanced epidemiological surveillance and contact management. A polymerase chain reaction assay, based on a restriction fragment l...

1999
Margery Kennett Vicki Stambos

The National Neisseria Network has undertaken meningococcal isolate surveillance by means of a collaborative laboratory-based initiative since 1994. The phenotype (serogroup, serotype and serosubtype) and antibiotic susceptibility of 323 isolates of Neisseria meningitidis from invasive cases of meningococcal disease were determined in 1998. Ninety per cent of the invasive isolates were either s...

Journal: :Communicable diseases intelligence 1999

The National Neisseria Network has undertaken meningococcal isolate surveillance by means of a collaborative laboratory-based initiative since 1994. The phenotype (serogroup, serotype and serosubtype) and antibiotic susceptibility of 323 isolates of Neisseria meningitidis from invasive cases of meningococcal disease were determined in 1998. Ninety per cent of the invasive isolates were either s...

Journal: :Drugs of today 2009
S P Verweij C J Bax K D Quint W G V Quint A P van Leeuwen R P H Peters P M Oostvogel J A Mutsaers P J Dörr J Pleijster S Ouburg S A Morré

Chlamydia trachomatis serovars are divided into three serogroups, namely serogroup B, serogroup I (Intermediate) and serogroup C, and subsequently into 19 different serovars. Worldwide, serogroup B is the most prevalent followed by serogroup I. Clear differences have been observed in the duration of infection and growth kinetics between serovars from different serogroups in murine and cell cult...

Journal: :Pediatrics 2015
Lucy A McNamara Alice M Shumate Peter Johnsen Jessica R MacNeil Manisha Patel Tina Bhavsar Amanda C Cohn Jill Dinitz-Sklar Jonathan Duffy Janet Finnie Denise Garon Robert Hary Fang Hu Hajime Kamiya Hye-Joo Kim John Kolligian Janet Neglia Judith Oakley Jacqueline Wagner Kathy Wagner Xin Wang Yon Yu Barbara Montana Christina Tan Robin Izzo Thomas A Clark

BACKGROUND In 2013-2014, an outbreak of serogroup B meningococcal disease occurred among persons linked to a New Jersey university (University A). In the absence of a licensed serogroup B meningococcal (MenB) vaccine in the United States, the Food and Drug Administration authorized use of an investigational MenB vaccine to control the outbreak. An investigation of the outbreak and response was ...

Journal: :Pediatrics 2016

This policy statement provides recommendations for the prevention of serogroup B meningococcal disease through the use of 2 newly licensed serogroup B meningococcal vaccines: MenB-FHbp (Trumenba; Wyeth Pharmaceuticals, a subsidiary of Pfizer, Philadelphia, PA) and MenB-4C (Bexsero; Novartis Vaccines, Siena, Italy). Both vaccines are approved for use in persons 10 through 25 years of age. MenB-F...

Journal: :Communicable diseases intelligence quarterly report 2009
John Tapsall

In 2007 there were 281 laboratory-confirmed cases of invasive meningococcal disease analysed by the National Neisseria Network, a nationwide network of reference laboratories. The phenotypes (serogroup, serotype and serosubtype) and antibiotic susceptibility of 154 isolates of Neisseria meningitidis from invasive cases of meningococcal disease were determined and an additional 127 cases were co...

Journal: :The New England Journal of Medicine 2021

Neisseria meningitidis serogroups A, B, C, W, X, and Y cause outbreaks of meningococcal disease. Quadrivalent conjugate vaccines targeting the are available. A pentavalent vaccine that also includes serogroup X (NmCV-5) is under development.

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید